By: Saheli Chowdhury
Liver is the largest gland of our body, making up around 2-3% of our body weight. The liver is rightfully called the “human metabolism laboratory” because it is responsible for all major metabolism related activities of our body and is the metabolic hub. Besides, it also harbors a complex architecture and is composed of diverse cells. Each of these cell types have specific biological roles that work together to regulate hepatic physiology on several levels. Hepatocytes are the principal cells which largely coordinate the major metabolic pathways. Based on the location of hepatocytes, the liver is divided into three zones (Zone 1, 2, and 3) with distinct functions. Proper maintenance of these zones is key to hepatic homeostasis. Hepatic stellate cells (HSCs) are another type of liver cells that can exist in two states. In their resting state, they serve to store vitamin A. Under conditions of liver injury, HSCs “switch” to an activated state under the influence of numerous factors and are classically known to be mediators of liver fibrogenesis. Fibrogenesis or fibrosis is a state where normal liver tissue is replaced by a hard scar tissue which renders the liver incapable of functioning normally. Liver cells do not function independently, with a complex network of crosstalk existing among hepatic cells with each cell type regulating the functioning of others.
Of late, there has been an alarming increase in the usage of terms like Metabolic Syndrome and “Fatty Liver” (also called Metabolic Dysfunction Associated Steatotic Liver Disease or MASLD). This happens under conditions of metabolic overload when normal physiology of the liver is perturbed culminating into forms of hepatic injuries. This triggers a burgeoning process which results in irreversible damage and in many cases leads to liver failure with dire consequences. Liver is also known to be a tremendously flexible organ capable of regenerating itself after injury or surgery. Almost all chronic liver diseases follow a similar pathogenesis and culminate into fibrosis. HSCs are usually considered a villain because they trigger liver fibrosis. They get activated by various inducers and signals of liver injury and expedite the fibrogenesis reaction. Just as good things have a bad side to them, even bad things have a good side to them! So how do HSCs bring out their heroic side?
Recently, Columbia postdoc Atsushi Sugimoto and his colleagues unraveled novel functions of HSCs, not linked to fibrogenesis. The authors discovered that HSCs and hepatocytes participate in a unique crosstalk to maintain proper hepatocytes zonation, mediate metabolism-associated functions, response to injury, and subsequent liver regeneration. Cells are capable of communicating via secreted molecules. A molecule secreted from one cell acts as a ligand which binds to cognate receptors present in the other cell type thereby perpetuating a downstream response. In case of HSCs, they secrete the signal molecule RSPO3, a protein which binds to its specific receptors (LGR4 and LGR5), enriched in hepatocytes.
The study found that when HSCs were depleted by expression of a toxin in mice liver, liver regeneration was impaired. HSC depleted livers showed an expansion of Zone 1 and condensed Zone 3. Using various biochemical and bioinformatics tools the authors described an increased secretion of RSPO3 in HSCs and its subsequent reduction upon HSC depletion. Further, deletion of receptors of RSPO3 in mice hepatocytes caused altered zonation and regeneration, showing that RSPO3 is pivotal in determining liver zonation. When RSPO3 was reintroduced in HSC-depleted mice livers, the ability of the liver to regenerate from injuries was adequately restored.
Figure 1: Schematic representation of the study showing cell-cell communication between HSCs and hepatocytes and the functions they regulate. Image generated using BioRender
The study by Sugimoto and his colleagues describes a protective, beneficial role of HSCs that is accomplished by secreting RSPO3 (Figure 1) which in turn, participates in intracell communication with hepatocytes to help ensure hepatic homeostasis. The dual functions of HSCs suggest that if activated “bad” HSCs could be reverted to their resting “good” state and further modified to release more RSPO3, it would ultimately aid in improving liver healing. This discovery suggests therapeutic potential in targeting HSCs to further enhance their protective effects and abrogate progression of chronic liver diseases.
Reviewed by: Margarita Angelova, Divya Vimal